About us
- >
- About us >
- Information >
- Announcement
2022-07-11
The clinical Phase II trial results of our company's novel diabetic foot ulcer healing drug (ENERGI-F703 GEL) have been published in the internat
We are thrilled to announce that the results of the Phase II clinical trial for ENERGI-F703 GEL have successfully passed the review of eClinicalMedicine and have been accepted for publication. This achievement not only validates the scientific rigor of our research but also significantly enhances the international recognition of our medication's development and facilitates our efforts in seeking new drug licensing opportunities.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00227-9/fulltext